Starpharma Holdings Net Worth 2011-2021 | SPHRY
Interactive chart of historical net worth (market cap) for Starpharma Holdings (SPHRY) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Starpharma Holdings net worth as of July 01, 2022 is $0.19B.
||Medical - Biomedical and Genetics
Starpharma Holdings Limited is engaged in the development of dendrimer products for pharmaceutical, life science and other applications. The Company's primary product in development is VivaGel, a microbicide gel for women used for the prevention and treatment of bacterial vaginosis and a range of sexually transmitted diseases. It also develops dendrimers as specialty chemicals for industrial applications. Starpharma Holdings Limited is headquartered in Melbourne, Australia.